Sugarloaf Wealth Management, LLC Coh Bar, Inc. Transaction History

Sugarloaf Wealth Management, LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 03, 2023	BUY	$1.51 - $3.4 $1,840 - $4,144	1,219 New	1,219 $2,000
Q2 2022 Jul 12, 2022	BUY	$0.17 - $0.34 $5,899 - $11,798	34,700 New	34,700 $7,000
Q1 2022 Apr 25, 2022	SELL	$0.25 - $0.43 $7,425 - $12,771	-29,700 Closed	0 $0
Q4 2021 Jan 20, 2022	BUY	$0.34 - $1.0 $2,482 - $7,300	7,300 Added 32.59%	29,700 $10,000
Q3 2021 Oct 20, 2021	SELL	$0.96 - $1.62 $732 - $1,236	-763 Reduced 3.29%	22,400 $22,000
Q2 2021 Jul 20, 2021	SELL	$1.09 - $1.49 $4,345 - $5,940	-3,987 Reduced 14.69%	23,163 $32,000
Q1 2021 Apr 19, 2021	BUY	$1.26 - $2.02 $630 - $1,010	500 Added 1.88%	27,150 $37,000
Q4 2020 Feb 03, 2021	BUY	$0.9 - $1.54 $23,985 - $41,041	26,650 New	26,650 $36,000
Q3 2020 Nov 03, 2020	SELL	$0.87 - $2.08 $8,482 - $20,280	-9,750 Closed	0 $0
Q2 2020 Jul 21, 2020	SELL	$1.08 - $4.0 $3,780 - $14,000	-3,500 Reduced 26.42%	9,750 $17,000
Q1 2020 Apr 15, 2020	BUY	$1.01 - $2.74 $1,767 - $4,795	1,750 Added 15.22%	13,250 $15,000
Q4 2019 Jan 29, 2020	BUY	$1.2 - $2.34 $13,800 - $26,910	11,500 New	11,500 $18,000

1.14K

Ticker CWBR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,906,940
Market Cap $1.57M
Description
CohBar, Inc., a clinical stage biotechnology company, focuses in the research and development of mitochondria based therapeutics (MBTs) for the treatment of chronic and age-related diseases. The company develops MBTs to treat non-alcoholic steatohepatitis (NASH), obesity, fatty liver disease, idiopathic pulmonary fibrosis, type 2 diabetes, acute...

Get notified when there are updates to the investment portfolio of Sugarloaf Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Sugarloaf Wealth Management, LLC with notifications on news.